{
    "title": "BRIEF-GlaxoSmithKline Posts FY COVID-19 Solutions Sales \u00a31.4 Bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10492897/BRIEF-GlaxoSmithKline-Posts-FY-COVID-19-Solutions-Sales-1-4-Bln.html",
    "date": "2022-02-09",
    "keywords": [
        "gsk",
        "cer",
        "growth",
        "business",
        "profit",
        "fy",
        "operating",
        "year",
        "track",
        "consumer",
        "healthcare",
        "mid2022",
        "aer",
        "biopharma",
        "contribution",
        "percentage",
        "glaxosmithkline",
        "plc",
        "revenue",
        "dividend",
        "q4",
        "level",
        "guidance",
        "proportion",
        "margin",
        "xevudy",
        "specialty",
        "decrease",
        "benefit",
        "income",
        "settlement",
        "whole",
        "vaccine",
        "covid19",
        "vaccination",
        "disruption",
        "impact",
        "half",
        "turnover",
        "shingrix",
        "record",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}